Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
Nature Reviews. Cardiology|April 2, 2020
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmiaJoerg Herrmann
European Heart Journal|November 26, 2019
From trends to transformation: where cardio-oncology is to make a differenceJoerg Herrmann
JACC. Cardiooncology|August 16, 2021
Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer: Looking for Something Heavier Than Heavy MetalJoerg Herrmann
Cardiovascular Research|December 7, 2005
Large meals and large arteries: is resistin the link?Joerg Herrmann
European Heart Journal Open|September 19, 2022
Cardiotoxicity assessment in breast cancer patients: is it straining?Hector Villarraga, Joerg Herrmann
Echo Research and Practice|September 8, 2016
Cardiac tumors: echo assessmentRekha Mankad, Joerg Herrmann
Trends in Cardiovascular Medicine|August 26, 2014
An update on cardio-oncologyJoerg Herrmann, Amir Lerman
Journal of Thoracic Disease|June 11, 2019
Erratum to arterial events in cancer patients-the case of acute coronary thrombosisOren Ohad, Joerg Herrmann
Mayo Clinic Proceedings|August 6, 2017
In Reply II-A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology RevisitedFeilong Wang, Joerg Herrmann
The New England Journal of Medicine|February 4, 2011
Myocardial infarction due to percutaneous coronary interventionAbhiram Prasad, Joerg Herrmann
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
Nature Reviews. Cardiology|April 2, 2020
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmiaJoerg Herrmann
European Heart Journal|November 26, 2019
From trends to transformation: where cardio-oncology is to make a differenceJoerg Herrmann
JACC. Cardiooncology|August 16, 2021
Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer: Looking for Something Heavier Than Heavy MetalJoerg Herrmann
Cardiovascular Research|December 7, 2005
Large meals and large arteries: is resistin the link?Joerg Herrmann
European Heart Journal Open|September 19, 2022
Cardiotoxicity assessment in breast cancer patients: is it straining?Hector Villarraga, Joerg Herrmann
Echo Research and Practice|September 8, 2016
Cardiac tumors: echo assessmentRekha Mankad, Joerg Herrmann
Trends in Cardiovascular Medicine|August 26, 2014
An update on cardio-oncologyJoerg Herrmann, Amir Lerman
Journal of Thoracic Disease|June 11, 2019
Erratum to arterial events in cancer patients-the case of acute coronary thrombosisOren Ohad, Joerg Herrmann
Mayo Clinic Proceedings|August 6, 2017
In Reply II-A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology RevisitedFeilong Wang, Joerg Herrmann
The New England Journal of Medicine|February 4, 2011
Myocardial infarction due to percutaneous coronary interventionAbhiram Prasad, Joerg Herrmann
Pageof 27